Difference between revisions of "Prednisone (Sterapred)"
Jump to navigation
Jump to search
m |
m |
||
| Line 22: | Line 22: | ||
**[[Mantle cell lymphoma]] | **[[Mantle cell lymphoma]] | ||
**[[Marginal zone lymphoma]] | **[[Marginal zone lymphoma]] | ||
| + | **[[Non-Hodgkin lymphoma, pediatric]] | ||
**[[Peripheral T-cell lymphoma]] | **[[Peripheral T-cell lymphoma]] | ||
| Line 37: | Line 38: | ||
*[[Multiple myeloma]] | *[[Multiple myeloma]] | ||
*[[Myelofibrosis]] | *[[Myelofibrosis]] | ||
| − | |||
*[[Post-transplant lymphoproliferative disorder]] | *[[Post-transplant lymphoproliferative disorder]] | ||
*[[Primary mediastinal B-cell lymphoma]] | *[[Primary mediastinal B-cell lymphoma]] | ||
Revision as of 00:30, 25 May 2022
General information
Class/mechanism: Corticosteroid, glucocorticoid.[1][2]
Route: PO
Extravasation: n/a
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Diseases for which it is established
- B-cell acute lymphoblastic leukemia
- Hodgkin lymphoma
- Langerhans cell histiocytosis
- Non-Hodgkin lymphoma
Diseases for which it is used
- Acquired coagulopathy
- B-cell lymphoma of mucosa-associated lymphoid tissue
- Chronic lymphocytic leukemia
- Erdheim-Chester disease
- High-grade glioma, pediatric
- Hodgkin lymphoma, nodular lymphocyte-predominant
- Immune thrombocytopenia (ITP)
- Large granular lymphocytic leukemia
- Mediastinal gray-zone lymphoma
- Multiple myeloma
- Myelofibrosis
- Post-transplant lymphoproliferative disorder
- Primary mediastinal B-cell lymphoma
- Prostate cancer
- Smoldering multiple myeloma
- T-cell acute lymphoblastic leukemia
- Thymoma
- Transformed lymphoma
- Waldenström macroglobulinemia
Diseases for which it was used
Patient drug information
- Prednisone (Sterapred) patient drug information (Chemocare)[3]
- Prednisone (Sterapred) patient drug information (UpToDate)[4]
Also known as
- Generic names: pred
- Brand names:
| Synonyms | |||||||
|---|---|---|---|---|---|---|---|
| Artinizona | Artrizona | Becortem | Bersen | Colisone | Cortancyl | Corticorten | Cortigen |
| Cortiol | Cortiprex | Cutason | Dacortin | Decortancyl | Decortin | Decortisyl | Dehydrocortison |
| Delcortin | Dellacorta | Delta-Cortisone | Delta Cortelan | Deltacortene | Deltacortone | Deltason | Deltasone |
| Deltisona | Dispersona | Drazone | Econosone | Ednaprom | Encorton | Erlanison | Flamacorten |
| Hostacortin | Ifison | Isolone | Lisacort | ME Korti | Meticorten | Nisocortec | Nisona |
| Nisone | Nizon | Nosipren | Novoprednisone | Orasone | Panafcort | Panasol-S | Pehacort |
| Pharmapred | Precortil | Predcort | Predeltin | Predicor | Predicorten | Predinis | Preditec |
| Prednax | Prednicap | Prednicen-M | Prednilonga-Retard | Predniment | Prednison | Prednisona | Prednisonum |
| Prednitone | Predson | Predsone | Predval | Procion | Prolix | Pronison | Pulmison |
| Rayos | Rectodelt | Senterlic | Sone | Steerometz | Sterapred | Trolic | Ultracorten |
| Vitazon | Winpred | ||||||
References
Categories:
- Drugs
- Oral medications
- Immunosuppressants
- Steroids
- Adult T-cell leukemia-lymphoma medications
- Anaplastic large cell lymphoma medications
- B-cell acute lymphoblastic leukemia medications
- Burkitt lymphoma medications
- Chronic lymphocytic leukemia medications
- Acquired coagulopathy medications
- Diffuse large B-cell lymphoma medications
- Erdheim-Chester disease medications
- Follicular lymphoma medications
- HIV-associated lymphoma medications
- Hodgkin lymphoma medications
- Hodgkin lymphoma, nodular lymphocyte-predominant medications
- Immune thrombocytopenia medications
- Langerhans cell histiocytosis medications
- Large granular lymphocytic leukemia medications
- MALT lymphoma medications
- Mantle cell lymphoma medications
- Marginal zone lymphoma medications
- Mediastinal gray-zone lymphoma medications
- Multiple myeloma medications
- Myelodysplastic syndrome medications
- Myelofibrosis medications
- Peripheral T-cell lymphoma medications
- Post-transplant lymphoproliferative disorder medications
- Primary mediastinal B-cell lymphoma medications
- Prostate cancer medications
- Smoldering multiple myeloma medications
- T-cell acute lymphoblastic leukemia medications
- Thymoma medications
- Transformed lymphoma medications
- Waldenström macroglobulinemia medications
- Breast cancer medications (historic)
- Chronic myelogenous leukemia medications (historic)
- Light-chain (AL) amyloidosis medications (historic)
- Medulloblastoma medications (historic)
- FDA approved in 1955